A retrospective, observational chart review study evaluating Ipilimumab-Associated Colitis: A Single-Center Experience.
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacodynamics
- 06 Jan 2017 New trial record